Arax Advisory Partners’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.9K Buy
+2,563
New +$68.8K ﹤0.01% 2827
2026
Q1
Sell
-90
Closed -$2.92K 4034
2025
Q4
$2.92K Buy
+90
New +$3.85K ﹤0.01% 3109
2025
Q3
Sell
-680
Closed -$33.9K 3904
2025
Q2
$33.9K Buy
+680
New +$30.7K ﹤0.01% 1423
2024
Q4
Sell
-324
Closed -$5.97K 2559
2024
Q3
$5.97K Hold
324
﹤0.01% 1642
2024
Q2
$6.54K Buy
+324
New +$5.39K ﹤0.01% 1471

Other funds holding HIMS

Arax Advisory Partners's HIMS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 2,563 shares worth $88.9K. The stake represents ﹤0.01% of the portfolio and ranks #2827 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in HIMS as recently as Q4 2025.

Arax Advisory Partners first reported a position in HIMS in Q2 2024 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Arax Advisory Partners held 2,563 shares of Hims & Hers Health worth $88.9K as of Q2 2026.
  • Hims & Hers Health was a new Arax Advisory Partners position in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2827 holding.
  • Arax Advisory Partners first reported a position in Hims & Hers Health in Q2 2024 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.